腫瘤壞死因子受體II(TNF-RII)存在于大多數(shù)細(xì)胞類型上,并且被認(rèn)為在TNF-α的刺激中發(fā)揮突出作用。TNFRII蛋白由造血細(xì)胞表達(dá),包括巨噬細(xì)胞、嗜中性粒細(xì)胞、淋巴細(xì)胞、胸腺細(xì)胞和肥大細(xì)胞。它由多種其他細(xì)胞類型表達(dá),包括內(nèi)皮細(xì)胞、心肌細(xì)胞和前列腺細(xì)胞 抗小鼠TNFR 2(TR 75 -54.7)體內(nèi)抗體-低內(nèi)毒素該產(chǎn)品同種型對(duì)照:Armenian Hamster IgG Isotype Control for In Vivo - Low Endotoxin [PIP] (ICH2251) 緩沖液:ICH3001-100ml,nICH3002-100ml,nICH3003-100ml, 濃度:1.0 mg/ml 純度:>95% by SDS-PAGE and HPLC 內(nèi)毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium or preservatives added.
應(yīng)用類型
Immunoprecipitation, Western Blot, Blocking, Flow Cytometry, ELISA